Back

Renal safety of a natriuresis-guided diuretic strategy in hospitalised heart failure

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Navigating the cardio-renal syndrome (2) Diuretics Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sahiljeet Singh

Hartford Hospital, Hartford (United States of America)

5 More presentations in this session

Presentation thumbnail
Renal and electrolyte safety of acetazolamide Add-On decongestion in heart failure: a systematic review
Doctor R. Ali (Pembroke Pines, US)
Abstract
Presentation thumbnail
Predicting diuretic resistance without urine output in acute heart failure
Mrs E. Vice (Atlanta, US)
Abstract
Presentation thumbnail
Thiazides attenuate the diuretic response to pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patients
Doctor D. Ceelen (Groningen, NL)
Abstract
Presentation thumbnail
Sustained low-efficiency dialysis for refractory congestion in advanced cardiorenal syndrome: haemodyamics and weight reduction analysis
Doctor G. Mihelcic (London, GB)
Abstract
Presentation thumbnail
Hyperkalemia incidence and recurrence among patients with heart failure - predictors and temporal trends
Doctor F. Lindberg (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
Navigating the cardio-renal syndrome (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
The basis: diuretic pharmacology and diuretic resistance
thumbnail
Congress Presentation
Tips and tricks in combining diuretics
thumbnail
Congress Session
Diuretic therapy: the science beyond the practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources